U.S. Life Sciences Stock News

In recent weeks, American Assets Trust's Executive Chairman Ernest S. Rady bought over US$212,000 of company stock across two transactions, lifting his indirect holdings to more than 8.1 million shares, shortly after the REIT posted mixed fourth-quarter 2025 results with earnings per share below forecasts but revenue ahead of expectations. These insider purchases come as commercial real estate sentiment weakens and interest rates remain elevated, suggesting leadership sees the portfolio’s...

Centerspace (CSR) drew fresh attention after releasing fourth quarter and full year 2025 results, issuing 2026 earnings guidance that points to a net loss, and reaffirming its quarterly dividend payout. See our latest analysis for Centerspace. The latest earnings update and guidance arrived after a stretch where the 1 year total shareholder return was roughly flat at 0.05%, even as the share price return year to date declined 6.08%. This hints that momentum has softened despite dividends...

In February 2026, Portland General Electric reported full-year 2025 revenue of US$3,576 million and net income of US$306 million, while also disclosing lower earnings per share than the prior year. On the same day, the company completed a roughly US$480 million follow-on common stock offering, signaling a major capital raise that meaningfully alters its equity base and funding mix. We’ll now examine how this substantial equity issuance may influence Portland General Electric’s investment...

In February 2026, BioLife Solutions, Inc. reported fourth-quarter 2025 sales of US$24.76 million, full-year 2025 sales of US$96.21 million, a reduced full-year net loss of US$4.60 million, and issued 2026 revenue guidance of US$112.5 million to US$115.0 million alongside an expectation of GAAP net income for the year. Management highlighted that growth was primarily driven by its biopreservation media franchise, now embedded in multiple approved cell and gene therapies, supported by a...

Anywhere Real Estate Inc. has released its full-year 2025 results, reporting revenue of US$5,960 million compared with US$5,692 million in 2024, and a net loss of US$90 million versus US$128 million previously. The combination of higher revenue and a smaller net loss points to operational progress that investors may see as a sign of improving financial health, even though the business remains loss-making. We’ll now examine how this revenue growth and reduced net loss might reshape Anywhere...

Omnicell (OMCL) is drawing fresh investor attention after its shift toward software and services was underscored by the ANiGENT acquisition, a move that centers on drug diversion detection and recurring revenue potential. See our latest analysis for Omnicell. While Omnicell’s latest software-focused move has caught attention, the share price tells a mixed story, with a 90 day share price return of 13.79% contrasting with a 5 year total shareholder return decline of 66.95%, suggesting recent...

In late February 2026, LifeStance Health Group reported fourth-quarter 2025 revenue of US$382.2 million and net income of US$11.7 million, issued 2026 revenue guidance of US$1.615 billion to US$1.655 billion, authorized a US$100 million share repurchase plan, and filed follow-on and shelf registrations for new common stock offerings. Together, the return to profitability, expanded capital markets activity, and planned buybacks highlight how LifeStance is actively reshaping its balance...

In late February 2026, Triumph Financial, Inc.’s board declared a quarterly cash dividend of US$17.81 per share on its 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferred Stock, with holders of NYSE-listed depositary shares receiving US$0.44525 per share payable on March 30, 2026 to investors of record on March 15, 2026. This routine preferred dividend, alongside fresh inflation data that may influence Federal Reserve policy, highlights the contrast between Triumph’s capital return...

Hawaiian Electric Industries (NYSE: HE) is advancing the resolution of Maui wildfire tort claims, supported by recent favorable court decisions. The company reports progress on a broader settlement framework that aims to bring more clarity to wildfire-related liabilities. HE has secured additional financial flexibility through new utility debt issuance and an expanded revolving credit facility. The utility is continuing to work toward its renewable energy targets while addressing...

In February 2026, Pilgrim's Pride reported Q4 2025 earnings that exceeded analyst expectations, driven by strong US operations with volume gains in its fresh portfolio and share growth for the Just Bare prepared foods brand, alongside supportive European performance and weaker results in Mexico. The results highlight how Pilgrim's Pride's focus on higher-value prepared foods and branded offerings like Just Bare is increasingly influencing the mix of its global earnings. We’ll now examine how...

If you are wondering whether Sensata Technologies Holding's current share price reflects its true worth, you are not alone. Many investors are asking the same question. The stock last closed at US$37.34, with returns of 0.9% over 7 days, 8.0% over 30 days, 7.0% year to date and 38.8% over 1 year, while the 3 year and 5 year returns sit at 23.7% and 33.1% declines respectively. These mixed returns set the scene for a closer look at what recent developments might mean for the business and its...

Why Sinclair Is On Investors’ Radar Right Now Sinclair (SBGI) has drawn attention after recent share price moves, with the stock around $16.34 and showing double digit returns over the past month and past three months, prompting fresh interest in its current valuation. See our latest analysis for Sinclair. The recent momentum, with a 7 day share price return of 11.92% and 30 day share price return of 12.61% at a current share price of $16.34, sits alongside a 1 year total shareholder return...

O’Reilly Automotive has already outlined plans in its 2025 Form 10-K to open 225 to 235 new stores in 2026, while integrating its 2024 acquisition of Groupe Del Vasto and expanding its dual DIY and professional automotive parts offering across North America. Recent commentary highlights that, even as inflation and tariffs pressure the do-it-yourself segment, O’Reilly’s professional business and distribution network are supporting ongoing expansion and attracting renewed attention from...

Hyatt Hotels (H) is back on investors’ radar after recent share price moves, with the stock showing mixed short term performance and a stronger picture over the past year and multi year periods. See our latest analysis for Hyatt Hotels. The latest 5.7% one day share price decline to US$161.50 comes after a period of steadier gains, with a 1 year total shareholder return of 15.8% and 5 year total shareholder return of 86.9%. This suggests longer term momentum remains intact despite short term...

Schlage, part of Allegion, has launched the Aspect Collection of interior door hardware, focused on bold design and easier installation. The collection expands Allegion's design centric portfolio and targets homeowners and professionals looking for more modern style options. The announcement highlights Allegion's emphasis on combining aesthetics with everyday usability in its residential product lineup. For investors watching Allegion (NYSE:ALLE), the Aspect Collection lands at a time when...

Bastion Asset Management has opened a significant new equity position in Parsons (NYSE:PSN). The holding ranks as a substantial position within Bastion’s portfolio. The move adds a new institutional holder to Parsons, which focuses on government and critical infrastructure projects. Parsons, traded on the NYSE under the ticker PSN, works across defense, intelligence, and critical infrastructure, areas that often rely on long term federal and public sector contracts. For investors watching...

Covista Inc., formerly Adtalem Global Education Inc., has completed a full corporate rebrand and name change. The company has also updated its ticker symbol to NYSE:CVSA. Alongside the rebrand, Covista introduced a three year growth plan targeting the U.S. healthcare workforce shortage. Covista operates in healthcare education, a segment that sits at the center of ongoing shortages across many clinical roles in the U.S. The company is presenting its new identity and plan as a response to...

Rubrik (NYSE:RBRK) is drawing fresh attention as recent updates highlight strong revenue gains, high net retention, and solid margins. The company reports operating with a very low share of its target market, which points to meaningful room for further enterprise cybersecurity adoption. Management continues to emphasize Rubrik’s subscription-based model and high switching costs as key supports for its position in data security. At a share price of $51.96, NYSE:RBRK sits against a backdrop...

Lennox International recently reported its fourth-quarter 2025 results, with both earnings per share and revenue coming in below analyst forecasts, while director Shane D. Wall sold 100 shares of common stock on February 25, 2026. This combination of an earnings shortfall and insider selling has sharpened investor focus on how resilient Lennox’s longer-term HVAC growth story may be. We’ll now examine how the weaker-than-expected quarterly earnings could influence Lennox’s previously outlined...

Sysco has launched a new pilot program, Home Grown by Sysco, to expand locally sourced food offerings across select regions in North America. The company has also signed a nationwide distribution partnership with Reborn Coffee to support the coffee brand's franchise expansion across the United States. For investors watching NYSE:SYY, these moves come as Sysco trades around $91.16 per share, with returns of 25.5% year to date and 23.8% over the past year. The stock has also returned 29.6%...

If you are wondering whether Day One Biopharmaceuticals' current share price lines up with its underlying worth, you are not alone. The stock most recently closed at US$10.60, with a 7 day return of 10% decline, a 30 day return of 5% decline, gains of 19.8% year to date and 17% over the past year, while the 3 year return sits at 43.4% decline. Recent news around Day One has largely focused on its development stage oncology pipeline and ongoing progress in clinical programs, which can...

What the latest earnings tell you about Diversified Healthcare Trust Diversified Healthcare Trust (DHC) has just reported fourth quarter and full year 2025 results, showing lower quarterly sales but a narrower net loss, a combination that naturally puts the stock back on investors’ radar. See our latest analysis for Diversified Healthcare Trust. That earnings update landed after a strong run in the shares, with a 90 day share price return of 39.96% and a year to date share price return of...

MannKind (MNKD) is back in focus after partner United Therapeutics introduced a soft mist inhaler designed to compete with Tyvaso DPI, raising fresh questions around MannKind’s future royalty stream and overall risk profile. See our latest analysis for MannKind. The stock’s 7 day share price return of 40.79% and 30 day share price return of 43.25% follow earnings that paired higher revenue with a quarterly loss, while the United Therapeutics soft mist inhaler news sharply reset sentiment...

If you are wondering whether Kaiser Aluminum's current share price lines up with its underlying worth, this article walks through the key signals you will want to weigh. The stock last closed at US$130.14, with returns of 0.9% over 7 days, 6.1% over 30 days, 8.2% year to date, 90.5% over 1 year, 74.0% over 3 years, and 36.6% over 5 years. This performance sets an important backdrop for any value check. Recent coverage around Kaiser Aluminum has focused on how investors view its role within...